Ceftriaxone Market to Surpass US$ 2.2 Billion by 2031 as Rising...

added blog Other

2026-07-20 10:18:25 -

Ceftriaxone Market to Surpass US$ 2.2 Billion by 2031 as Rising Bacterial Infection Cases and Generic Drug Adoption Drive Sustainable Growth

The global Ceftriaxone Market continues to demonstrate steady growth as healthcare systems worldwide prioritize effective treatment options for bacterial infections. Valued at US$ 1.7 billion in 2021, the market is projected to expand at a compound annual growth rate (CAGR) of 2.9% from 2022 to 2031, reaching more than US$ 2.2 billion by the end of 2031. Increasing prevalence of urinary tract...

0 Comments 0 Shares 12 Views 0 Reviews